Caas Capital Management LP Viking Therapeutics, Inc. Transaction History
Caas Capital Management LP
- $288 Million
- Q2 2024
A detailed history of Caas Capital Management LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Caas Capital Management LP holds 17,207 shares of VKTX stock, worth $931,414. This represents 0.32% of its overall portfolio holdings.
Number of Shares
17,207
Previous 33,000
47.86%
Holding current value
$931,414
Previous $2.71 Million
66.3%
% of portfolio
0.32%
Previous 0.21%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
442Shares Held
63.3MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$547 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$326 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$277 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$122 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$101 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.15B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...